Related Experiment Video
Updated: Jul 17, 2025

Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
Nebulized caffeine alleviates airway hyperresponsiveness in a murine asthma model
Jeffrey M Loube1,2, Sarah Gidner3, Jarrett Venezia4
1Department of Environmental Health and Engineering, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States.
Nebulized caffeine improved lung function in mice with asthma. Aerosolized ultrafine caffeine particles reduced airway resistance and delayed maximum resistance, offering a potential new therapy for difficult asthma.
Area of Science:
- Pulmonary Medicine
- Pharmacology
- Respiratory Physiology
Background:
- Difficult asthma, often uncontrolled by conventional therapies, necessitates innovative treatments.
- Methylxanthines, like caffeine and theophylline found in coffee, have demonstrated beneficial effects for asthma patients.
- Caffeine's bronchodilatory effects are mediated through phosphodiesterase inhibition and bitter taste receptor agonism.
Purpose of the Study:
- To investigate the efficacy of aerosolized ultrafine caffeine particles in improving pulmonary function in a mouse model of asthma.
- To assess the impact of nebulized caffeine on airway hyperresponsiveness and lung pathophysiology.
Main Methods:
- Susceptible A/J mice were challenged with methacholine to induce airway hyperresponsiveness.
- Ultrafine caffeine particles (2.5-4 μm) were administered via nebulization.
- Pulmonary function was assessed using the forced oscillation technique; lung pathophysiology and bronchoalveolar lavage cell profiles were also analyzed.
Main Results:
- Aerosolized caffeine significantly reduced maximum airway resistance and delayed the time to reach maximum resistance in methacholine-challenged mice.
- Nebulized caffeine demonstrated a consistent effect on airway hyperresponsiveness across various doses.
- No significant lung pathology was observed in mice treated with nebulized caffeine compared to vehicle controls.
Conclusions:
- Direct aerosolization of caffeine to the lungs can effectively improve pulmonary function in a murine model of asthma.
- Nebulized caffeine presents a promising therapeutic strategy for managing airway hyperresponsiveness in difficult asthma.
- Further research into inhaled caffeine formulations may lead to novel treatments for respiratory diseases.
Related Concept Videos
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

